메뉴 건너뛰기
International Journal of Cardiology
Volumn 157, Issue 1, 2012, Pages 117-119
Inhibition of cardiomyocyte lysosomal activity in hydroxychloroquine cardiomyopathy
Author keywords

Cardiomyopathy; Drug toxicity; Hydroxichloroquine
Indexed keywords

ALPHA GALACTOSIDASE; ALPHA LEVO FUCOSIDASE; ALPHA MANNOSIDASE; BETA GALACTOSIDASE; BETA GLUCOSIDASE; BETA GLUCURONIDASE; CEREBROSIDE SULFATASE; HYDROXYCHLOROQUINE; LYSOSOME ENZYME;
EID: 84860231970     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.03.112     Document Type: Article
Times cited : (39)
References (5)
  • 1
    • 0035091683 scopus 로고    scopus 로고
    • Cardiac toxicity secondary to long term treatment with chloroquine
    • A. Cervera, G. Espinosa, J. Font, and M. Ingelmo Cardiac toxicity secondary to long term treatment with chloroquine Ann Rheum Dis 60 2001 301 302
    • (2001) Ann Rheum Dis , vol.60 , pp. 301-302
    • Cervera, A.1    Espinosa, G.2    Font, J.3    Ingelmo, M.4
  • 2
    • 0036754329 scopus 로고    scopus 로고
    • Chloroquine cardiotoxicity: Clinic-pathologic features in three patients and comparison with three patients with Fabry disease
    • J.M. Roos, M.C. Aubry, and W.D. Edwards Chloroquine cardiotoxicity: clinic-pathologic features in three patients and comparison with three patients with Fabry disease Cardiovasc Pathol 11 2002 277 283
    • (2002) Cardiovasc Pathol , vol.11 , pp. 277-283
    • Roos, J.M.1    Aubry, M.C.2    Edwards, W.D.3
  • 3
    • 81855227637 scopus 로고    scopus 로고
    • Statement of authorship and publishings Ethics in the International Journal of Cardiology
    • A.J.S. Coats, and L.G. Shewan Statement of authorship and publishings Ethics in the International Journal of Cardiology Int J Cardiol 153 2011 239 240
    • (2011) Int J Cardiol , vol.153 , pp. 239-240
    • Coats, A.J.S.1    Shewan, L.G.2
  • 4
    • 0141765881 scopus 로고    scopus 로고
    • Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease
    • F. Weidemann, F. Breunig, and M. Beer Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease Circulation 108 2003 1299 1301
    • (2003) Circulation , vol.108 , pp. 1299-1301
    • Weidemann, F.1    Breunig, F.2    Beer, M.3
  • 5
    • 12144287518 scopus 로고    scopus 로고
    • Fabry disease defined: Baseline clinical manifestations of 366 patients in the Fabry outcome survey
    • A. Mehta, R. Ricci, and U. Widmer Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry outcome survey Eur J Clin Invest 34 2004 236 242
    • (2004) Eur J Clin Invest , vol.34 , pp. 236-242
    • Mehta, A.1    Ricci, R.2    Widmer, U.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.